Thermo Fisher Opens New Singapore Sterile Vaccine Drug Facility
Thermo Fisher Scientific officially opened a new large-scale, high-speed sterile drug facility in Singapore for developing and manufacturing vaccines and therapeutics. The site supports end-to-end vaccine production locally, sterilising components separately before bringing them together, and complements recent Sanofi and BioNTech investments to strengthen regional supply-chain resilience after pandemic disruptions.